EPO and chronic kidney disease: The conversion of Epo-producing cells into myofibroblast-like cells and a coincident loss of Epo-producing ability are commonly found in vivo and in vitro and are believed to be a major cause of renal anemia and fibrosis in CKD patients [21,22].